The human CYP3A subfamily: practical considerations.
Wrighton
S A
SA
Department of Drug Disposition, Lilly Corporate Center, Indianapolis, Indiana 46285, USA.
Schuetz
E G
EG
Thummel
K E
KE
Shen
D D
DD
Korzekwa
K R
KR
Watkins
P B
PB
D001665:Binding Sites; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000145:classification* / Q000378:metabolism; D004347:Drug Interactions; D004790:Enzyme Induction; D006801:Humans; D007421:Intestine, Small / Q000201:enzymology; D007668:Kidney / Q000201:enzymology; D006899:Mixed Function Oxygenases / Q000096:biosynthesis / Q000145:classification* / Q000378:metabolism; D013379:Substrate Specificity
D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A